Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Parasomnias 2Lung Neoplasms 2Weight Loss 1Uveal Melanoma 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Smith-Magenis Syndrome 1Sleep Wake Disorders 1Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Cancer - Female 1Barrett Esophagus 1Autism Spectrum Disorder 1Anorexia 1Angelman Syndrome 1

Interventions

Carboplatin 66Cisplatin 57Paclitaxel 42Radiotherapy 35Pemetrexed 34Gemcitabine 31Docetaxel 31Etoposide 24pembrolizumab 21Vinorelbine 20Erlotinib Hydrochloride 13Magnetic Resonance Spectroscopy 12Gefitinib 11Specimen Handling 10Radiosurgery 10Drug Therapy 10Bevacizumab 10durvalumab 9Nivolumab 9Vinblastine 6Topotecan 6Surgical Procedures, Operative 6Cyclophosphamide 6Standard of Care 5Platinum 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Dexamethasone 5paclitaxel poliglumex 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lung Neoplasms × Melatonin × Clear all
NCT00668707 2021-08-03

AMPLCaRe

The Canadian College of Naturopathic Medicine

Phase 3 Completed
709 enrolled 25 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
82 enrolled 7 charts
GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡